＜6305＞ Hitachi Construction Machinery 3359 +13

A fight. Financial results for the 2nd quarter were announced last weekend, and operating income for the July-9 fiscal year was 38 billion yen, down 15.0% from the same period last year, and continued to decline by 2 digits in the first quarter. The full-year forecast has been revised downward from the previous year's 161 billion yen to 150 billion yen, down 7.8% from the previous fiscal year. It also seems to reflect the deterioration in general construction equipment demand in North America. Although the range of downward revisions is limited, there also seems to be a view that the recovery outlook for the US in the second half is somewhat optimistic.

＜9962＞ MISUMI G 2653.5 +131

Massive backlash. Financial results for the first half of the year were announced last weekend, and operating profit was 23.4 billion yen, up 26.3% from the same period last year, and surpassed the previous plan of 20.2 billion yen. Also, the full-year forecast was revised upward from the previous 46 billion yen to 49.1 billion yen. Strong performance in the Chinese market, such as large-scale telecommunications projects, and the depreciation effect of yen, etc. are seen as factors in the improvement in business performance. The upside for the first half of the year has been revised upward, but the movement that positively grasps the announcement of the upward correction while uncertainty about the future of the Chinese market has not been overcome prevails.

＜2801＞ Kikkman 1795 +90

Massive backlash. It was announced that 11 million shares, which is 1.15% of the number of issued shares, and treasury stock up to 15 billion yen will be acquired. The acquisition period is from 11/8 to 25/3/31. The purpose of the acquisition is to carry out flexible capital policies in response to changes in the business environment. In addition to being expected to be a supporting effect in terms of supply and demand for the time being, recent strong performance etc. are also being considered as a background for implementation. Also, it seems to be leading to expectations for the new mid-term plan scheduled to be announced next year.

＜7199＞ Premier Group 2435 +271

rapid expansion. Financial results for the first half of the year were announced last weekend, and profit before income tax was 4.08 billion yen, up 44.3% from the same period last year, and the profit rate of increase has further expanded since the same 33.3% increase in the first quarter. Although the full-year plan of 8 billion yen, an increase of 28.2% from the previous fiscal year, remains unchanged, earnings tend to accumulate every quarter, so it looks like upward expectations take precedence. In addition to expanding operating income due to the accumulation of credit receivables balances and failure guarantee balances, it seems that cost suppression is also progressing.

＜3562＞ No.1 1015 +150

Stops are highly proportional. The introduction of a shareholder benefit program was announced last weekend. Shareholders holding 300 shares or more on the last day of February and the end of August will each be presented with a QUO card worth 15,000 yen. The preferential yield for shareholders holding 300 shares is at the level of 11.6% based on last weekend's closing price. Increased yield is leading to positive evaluations. Shareholders will be eligible starting at the end of February '25.

＜4519＞ Chugai Pharmaceutical 7855 +986

skyrocketing. Financial results for the 3rd quarter were announced last weekend, and operating income for the July-9 fiscal year was 160.4 billion yen, up 50.4% from the same period last year, and the full-year forecast was revised upward from the previous 460 billion yen to 540 billion yen. The market consensus for the full year is estimated to have been around 500 billion yen. In addition to the hemophilic drug hemuribulab growing more than expected, the rheumatoid arthritis drug Actemura also seems to be doing well. The year-end dividend has yet to be changed, but expectations for dividend increases due to poor performance are also ahead of time.

＜7733＞ Olympus 2678 -160

The sharp decline continued. It has been announced that CEO Stefan Kaufmann has resigned. There also seems to be a suspicion that they were purchasing illegal drugs, and as a result of internal investigations, it was determined that there is a high possibility that they were acting contrary to the Code of Conduct, and it seems that the board of directors asked them to resign. For the time being, it is said that Chairman Takeuchi will assume the duties of CEO. Movements to be wary of the impact on future management and the decline in confidence in compliance are moving ahead.

＜5423＞ TOSTEEL 1608 -205

Plummeting. Financial results for the 2nd quarter were announced last weekend, and operating income for the July-9 fiscal year was 4.2 billion yen, down 54.4% from the same period last year, and the range of decline expanded. Incidentally, the full-year forecast was revised downward from the previous 32 billion yen to 24 billion yen. The market consensus was slightly higher than the previous company plan. Transient factors such as inventory evaluations are also included in the downturn in the first half, but it seems that a negative impact preceded the magnitude of the downward correction range, which was mainly due to a decrease in quantity due to deterioration in international supply and demand.

＜6954＞ FANUC 4016 +129

Significant continuous growth. Financial results for the first half of the year were announced last weekend, and operating profit was 75.6 billion yen, up 13.6% from the same period last year, and the full-year forecast, which surpassed the previous plan of 68.6 billion yen, was revised upward from 143 billion yen to 150.8 billion yen. The full year market consensus seems to have been around 148 billion yen. In the background, there are improvements in demand for robo-machines for IT. The volume of orders received has decreased compared to the previous quarter, but it seems that expectations for a further increase in full-year results are increasing, such as conservative exchange assumptions for the second half.

＜4063＞ Shin-Etsu Chemical 5593 -167

The sharp decline continued. Financial results for the 2nd quarter were announced last weekend, and operating profit for the July-9 fiscal year was 214.7 billion yen, up 12.3% from the same period last year, exceeding market expectations by about 10 billion yen. Meanwhile, the forecast for the fiscal year ending 2025/3 remains unchanged at 735 billion yen, up 4.8% from the previous fiscal year. In a form that reflects reviews etc. of exchange expectations to the appreciation of the yen. Furthermore, the fact that it shows a short-term slowdown in demand for PVC resins and wafers in the United States, and that there were no announcements of expected stock buybacks, etc. are negative factors.